SavedAdd your journal

Journals / Medicine Science / 2020 / Cilt: 9 - Sayı: 4

An investigation of olfactory bulb and entorhinal cortex volumes in both patients with Alzheimer’s disease and healthy individuals, and a comparative analysis of neuropeptides

Emine PETEKKAYA
Zülal KAPTAN
Demet ÜNALMIŞ
Gülen BURAKGAZİ
Berna KUŞ
İsmet Murat MELEK
Abdullah ARPACI
Pages
866–871
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

This outcome may indicate that an MRI scan examination of OB and EC volumes may help early AD diagnosis.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Alzheimer’s Disease (AD) is the most common neurodegenerative disease and is hard to diagnose at the early stages.
📊
Key Findings & Data:The participants comprised 9 AD patients and 12 healthy individuals.
💡
Conclusion & Impact:This outcome may indicate that an MRI scan examination of OB and EC volumes may help early AD diagnosis.
🔬Design:Research Article
📍Scope:Comprehensive Sample
⚙️Variables:Domain Parameters

Özet

Alzheimer’s Disease (AD) is the most common neurodegenerative disease and is hard to diagnose at the early stages. The pathogenesis of AD is associated with the loss of a sense of smell. Reduction in the volumes of the Olfactory Bulb (OB) and Entorhinal Cortex (EC) is positively correlated with the decline of the smelling function where OB projects to EC. This study aims to detect the early changes in OB and EC volumes in AD patients by comparing them to healthy subjects. This study also aims to make a comparative analysis of plasma levels and the relationship between arginine-vasopressin (AVP) and Oxytocin (OT), which are neuropeptides associated with cognitive functions. The participants comprised 9 AD patients and 12 healthy individuals. We used volumetric methods such as MRICloud and IBASPM to measure the OB and EC volumes with the help of 3D MRI (Magnetic Resonance Imaging) images. We compared the left and right differentiation. Moreover, we investigated the neuropeptide levels in blood samples from the participants. We conducted a correlation analysis for all parameters. Bilateral OB atrophy was discovered in the AD patients in comparison to the control group (p=0.002 for right; p=0.015 for left). The right OB volume was measured to be larger than the left OB volume in the control group,but this asymmetry was not observed in the AD patients. The right and left EC's of the AD patients were atrophic in comparison to the control (p<0.001). The atrophy of the left EC was measured to be higher than that of the right EC (p=0.0008). There was no significant difference between the OT and AVP plasma levels of the AD patients and the control group. The study revealed that the OB and EC volumes of the AD patients were bilaterally reduced in comparison to patients of similar ages. This outcome may indicate that an MRI scan examination of OB and EC volumes may help early AD diagnosis.

🔖

Cite This Article

PETEKKAYA, E., KAPTAN, Z., ÜNALMIŞ, D., BURAKGAZİ, G., KUŞ, B., MELEK, İ. M., ARPACI, A. (2020). An investigation of olfactory bulb and entorhinal cortex volumes in both patients with Alzheimer’s disease and healthy individuals, and a comparative analysis of neuropeptides. Medicine Science, Cilt: 9 - Sayı: 4, 866–871. https://ajindex.com/articles/276915

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (16)

  1. Marin C, Vilas D, Langdon C, et al. Olfactory dysfunction in neurodegenerative diseases. Curr Allergy Asthma Rep. 2018;18:42
  2. Jung HJ, Shin IS, Lee JE. Olfactory function in mild cognitive impairment and Alzheimer's disease: A meta-analysis. Laryngoscope. 2019;129:362-9
  3. Bathini P, Brai E, Auber LA. Olfactory dysfunction in the pathophysiological continuum of dementia. Ageing Res Rev. 2019;55:100956
  4. Murphy C. Olfactory and other sensory impairments in Alzheimer disease. Nat Rev Neurol. 2019;15:11-24
  5. DeVere R. Disorders of taste and smell. Continuum. 2017;23:421-46
  6. Daulatzai MA. Olfactory dysfunction: its early temporal relationship and neural correlates in the pathogenesis of Alzheimer's disease. J Neural Transm. 2015;122:1475-97
  7. Lu J, Wang X, Qing Z, et al. Detectability and reproducibility of the olfactory fMRI signal under the influence of magnetic susceptibility artifacts in the primary olfactory cortex. Neuroimage. 2018;178:613-21
  8. Asal N, Bayar Muluk N, Inal M, et al. Olfactory bulbus volume and olfactory sulcus depth in psychotic patients and patients with anxiety disorder/ depression. Eur Arch Otorhinolaryngol. 2018;275:3017-24
  9. Gellrich J, Han P, Manesse C, et al. Brain volume changes in hyposmic patients before and after olfactory training. Laryngoscope. 2018;128:1531-6
  10. Chapuis J, Cohen Y, He X, et al. Lateral entorhinal modulation of piriform cortical activity and fine odour discrimination. J Neurosci. 2013;33:13449-59
  11. Fliers E, Swaab DF, Pool CW, et al. The vasopressin and oxytocin neurons in the human supraoptic and paraventricular nucleus; changes with aging and in senile dementia. Brain Res. 1985;342:45-53
  12. McKhann G, Drachman D, Folstein M, et al. Clinical diagnosis of Alzheimer’s disease: report of the NINCDS-ADRDA work group under the auspices of department of health and human services task force on alzheimer’s disease. Neurology. 1984;34:939–44
  13. Acer N, Turgut M. Measurements of the insula volume using MRI. Island Reil Human Brain. 2018;101-11
  14. Han SH, Lee MA, An SS, et al. Diagnostic value of Alzheimer's diseaserelated individual structural volume measurements using IBASPM. J Clin Neurosci. 2014;21:2165-9
  15. Lucassen PJ, Tilders FJ, Salehi A, et al. Neuropeptides vasopressin (AVP), oxytocin (OXT) and corticotropin-releasing hormone (CRH) in the human hypothalamus: activity changes in aging, Alzheimer's disease and depression. Aging. 1997;9:48-50
  16. Meynen G, Unmehopa UA, van Heeri